Antiviral agents and uses thereof
Grant
US12590092B2
Kind: B2
Mar 31, 2026
Assignee
GRIFFITH UNIVERSITY
Inventors
Mark Von Itzstein, Ibrahim El-Deeb, Patrice Guillon, Larissa Heilig
Abstract
The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: and to pharmaceutical compositions comprising the compound. In Formula (I), R3 is selected from the group consisting of: wherein rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection.
CPC Classifications
A61P 31/16
C07D 471/04
C07D 487/04
C07D 495/04
C07D 487/14
C07D 491/048
Filing Date
2022-01-28
Application No.
18263481
Claims
21